Brain cytoplasmic RNA 1 (BCYRN1)

Brain cytoplasmic RNA 1 (BCYRN1), also known as BC200 RNA, is a primate-specific long non-coding RNA (lncRNA) of about 200 nucleotides, predominantly expressed in the brain where it localizes to neuronal dendrites. Its primary physiological function is the inhibition of translation initiation, thereby regulating protein synthesis at synapses and contributing to synaptic plasticity. BCYRN1 achieves this by binding to translation initiation factors such as eIF4A and influencing RNA-protein interactions. Beyond its normal neuronal role, aberrant expression patterns of BCYRN1 are linked to several diseases: it is upregulated and promotes oncogenic processes by microRNA sponging in multiple cancers, but acts oppositely as a tumor suppressor in glioma, where reduced levels correlate with tumor progression. This complex, context-dependent functionality makes BCYRN1 a proposed biomarker and potential therapeutic target for cancer and neurological disease, but also presents challenges for therapeutic intervention due to its dual roles and tissue specificity.

Other names

BC200BC200aNCRNA00004LINC00004brain cytoplasmic RNA 200-alphanon-protein coding RNA 4long intergenic non-protein coding RNA 4BC200-alphabrain cytoplasmic RNA 1 (analog of mouse Bc1)brain cytoplasmic RNA 1 (non-protein coding)BCYRN1

BCYRN1 inhibits eukaryotic translation initiation by binding and modulating eIF4A RNA helicase activity. It also modulates protein synthesis at synapses via interaction with RNA-binding proteins such as poly(A)-binding protein (PABP) and hnRNPs. In cancer, it sponges microRNAs to affect oncogene expression.